Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers–reaching the frontiers of individual risk prediction

Phospholamban cardiomyopathy: a Canadian perspective on a unique population

(2019) C. C. Cheung et al.   Netherlands Heart Journal

A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy

(2019) Julia Cadrin-Tourigny et al.   EUROPEAN HEART JOURNAL

The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update

(2019) L. P. Bosman et al.   Netherlands Heart Journal

Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis

(2018) Laurens P. Bosman et al.   HEART RHYTHM

Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging

(2018) Wouter P te Rijdt et al.   European Heart Journal-Cardiovascular Imaging

Sudden Cardiac Death in the Young

(2016) Michael Ackerman et al.   CIRCULATION

Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications

(2016) Louise R.A. Olde Nordkamp et al.   HEART RHYTHM

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement

(2015) Gary S. Collins et al.   ANNALS OF INTERNAL MEDICINE

A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations

(2015) Grażyna T Truszkowska et al.   BMC Medical Genetics

A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia

(2015) Guan-Sheng Liu et al.   CARDIOVASCULAR RESEARCH

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

(2015) Silvia G. Priori et al.   EUROPEAN HEART JOURNAL

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

Inherited Cardiomyopathies

(2014) Jeffrey A. Towbin   CIRCULATION JOURNAL

Outcome in Phospholamban R14del Carriers: Results of a Large Multicentre Cohort Study

(2014) I. A. W. van Rijsingen et al.   Circulation-Cardiovascular Genetics

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

(2014)   EUROPEAN HEART JOURNAL

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

(2013) C. O'Mahony et al.   EUROPEAN HEART JOURNAL

Mortality of Inherited Arrhythmia Syndromes

(2012) Eline A. Nannenberg et al.   Circulation-Cardiovascular Genetics

Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy

(2012) Paul A. van der Zwaag et al.   EUROPEAN JOURNAL OF HEART FAILURE

Mutations in the human phospholamban gene in patients with heart failure

(2011) Alessandra Medeiros et al.   AMERICAN HEART JOURNAL

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed Modification of the Task Force Criteria

(2010) F. I. Marcus et al.   EUROPEAN HEART JOURNAL

Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes

(2009) Maximilian G. Posch et al.   HEART RHYTHM